CSBRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30
CHAMPIONS ONCOLOGY, INC.
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 11, 2026
$4.69−0.01 (-0.21%)
Close on Oct 19, 2026
- Market cap
- $65.18M
- P/E (TTM)
- –
- Dividend yield
- –
Champions Oncology statistics
Financials through Jul 31, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Market Cap | $65.28M | $164.85M |
| Enterprise Value | $61.49M | $87.06M |
| PS Ratio | 1.08 | 3.60 |
| PB Ratio | 16.77 | 2.03 |
| P/TBV Ratio | 18.35 | 2.31 |
Enterprise value
| Measure | Champions Oncology | Industry median |
|---|---|---|
| EV / Sales | 1.01 | 2.43 |
| EV / EBITDA | 212.02 | 14.69 |
Income (trailing twelve months)
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Revenue | $60.66M | $57.94M |
| Gross Profit | $30.22M | $90.47M |
| Operating Income | -$1.02M | -$21.44M |
| Pretax Income | -$892.00K | -$14.45M |
| Net Income | -$1.10M | -$22.46M |
| EBITDA | $290.00K | -$16.91M |
| EPS (Diluted) | -$0.08 | -$0.83 |
Margins
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Gross Margin | 49.8% | 52.3% |
| Operating Margin | -1.68% | -44.5% |
| Pretax Margin | -1.47% | -13.0% |
| Profit Margin | -1.82% | -39.2% |
| EBITDA Margin | 0.48% | -31.3% |
| FCF Margin | -10.1% | -8.85% |
Returns
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -29.8% | -53.1% |
| Return on Assets (ROA) | -3.46% | -41.0% |
| Return on Capital Employed (ROCE) | -7.02% | -37.8% |
Growth
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 6.65% | 6.01% |
| Net Income Growth (YoY) | -137.8% | -37.7% |
| EPS Growth (YoY) | -140.0% | -29.2% |
| FCF Growth (YoY) | -184.8% | 2.34% |
| Revenue Growth (3Y CAGR) | 3.33% | 2.25% |
| Revenue Growth (5Y CAGR) | 7.68% | 6.42% |
Balance sheet
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.36M | $62.42M |
| Net Cash (Debt) | $4.36M | $15.68M |
| Net Cash Per Share | $0.31 | $0.66 |
| Equity (Book Value) | $3.89M | $48.79M |
| Book Value Per Share | $0.28 | $1.36 |
| Tangible Book Value | $3.56M | $23.06M |
| Working Capital | $563.00K | $75.77M |
Financial position
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Current Ratio | 1.03 | 3.30 |
| Quick Ratio | 0.96 | 2.39 |
Cash flow (trailing twelve months)
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Operating Cash Flow | -$5.56M | -$12.35M |
| Capital Expenditures | -$573.00K | -$1.06M |
| Free Cash Flow | -$6.14M | -$20.28M |
| FCF Per Share | -$0.44 | -$0.42 |
Efficiency
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Asset Turnover | 1.90 | 0.38 |
| Revenue Per Employee | $283.46K | $398.96K |
| Profits Per Employee | -$5.16K | -$703.34K |
| Employee Count | 214 | 74 |
Dividends and yields
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Earnings Yield | -1.69% | -22.7% |
| FCF Yield | -9.40% | -9.07% |
Shares
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Shares Outstanding | 13,918,600 | 58,179,650 |
| Shares Change (YoY) | -1.20% | 11.1% |
| Shares Change (QoQ) | 0.23% | 0.54% |
| Float | 9,748,760 | 49,173,100 |
| Shares Held by Insiders | 30.0% | 11.6% |
| Shares Held by Institutions | 42.4% | 59.4% |
Taxes
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Income Tax | $243.00K | $91.50K |
Scores
| Measure | Champions Oncology | Industry median |
|---|---|---|
| Altman Z-Score | -0.33 | -0.24 |
| Piotroski F-Score | 3 | 4 |
| Beneish M-Score | -1.80 | -2.62 |
Calculated by StockData from Champions Oncology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.